Cytokinetics financials
WebMar 1, 2024 · SOUTH SAN FRANCISCO, Calif., March 01, 2024 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) reported financial results for the fourth quarter and full year 2024. Net loss for the fourth quarter was $137.4 million or $1.45 per share and the net loss for the year 2024 was $389.0 million or $4.33 per share. WebCYTK Finanicals Stock Screener Earnings Calendar Sectors Nasdaq CYTK U.S.: Nasdaq Cytokinetics Inc. Watch list Create CYTK Alert After Hours Last Updated: Mar 8, 2024 7:23 p.m. EST Delayed...
Cytokinetics financials
Did you know?
WebCytokinetics is a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics that modulate muscle function for the … WebApr 13, 2024 · The projected fair value for Cytokinetics is US$38.04 based on 2 Stage Free Cash Flow to Equity. Cytokinetics' US$34.05 share price indicates it is trading at similar levels as its fair value estimate
WebApr 10, 2024 · SOUTH SAN FRANCISCO, Calif., April 10, 2024 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that Robert I. Blum, … WebOperating Status Active. Last Funding Type Post-IPO Debt. Legal Name Cytokinetics, Inc. Stock Symbol NASDAQ:CYTK. Company Type For Profit. Contact Email [email protected]. Phone Number 6506243010. Cytokinetics is a late-stage biopharmaceutical company focused on discovering, developing and …
WebFeb 6, 2014 · Financial Guidance 2014. Cytokinetics also announced its financial guidance for 2014. The company anticipates cash revenue will be in the range of $19 to $21 million, cash R&D expenses will be in ... WebApr 10, 2024 · SOUTH SAN FRANCISCO, Calif., April 10, 2024 (GLOBE NEWSWIRE) — Cytokinetics, Incorporated ( Nasdaq: CYTK) today announced that Robert I. Blum, …
WebCYTK Cytokinetics Inc. Annual Income Statement - WSJ Subscribe Sign In Cytokinetics Inc. CYTK (U.S.: Nasdaq) View All companies AT CLOSE 4:00 PM EDT …
WebApr 10, 2024 · Forward-looking statements are not guarantees of future performance, and Cytokinetics' actual results of operations, financial condition and liquidity, and the development of the industry in which ... database.system.pool.maxsizeWebApr 12, 2024 · Finally, Truist Financial assumed coverage on Cytokinetics in a report on Tuesday, December 20th. They issued a “buy” rating and a $60.00 price target for the company. One research analyst has ... database systems by nenad jukic pdfWebApr 10, 2024 · Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. About the company Rewards Revenue is forecast to grow 46.65% per year Risk Analysis Negative shareholders equity bitlife mod apk everything unlockedWebCytokinetics, Inc. is a publicly traded biopharmaceutical company based in South San Francisco, California, that develops muscle activators and muscle inhibitors as potential … database systems 12th edition pdfWebMay 6, 2024 · SOUTH SAN FRANCISCO, Calif., May 06, 2024 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) reported financial results for the first quarter of 2024. Net loss for the first quarter was $47.1 million, or $0.66 per share, compared to net loss for the first quarter of 2024 of $39.4 million, or $0.66 per share. database system definitionWeb18 hours ago · Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) 04/03/23-4:00PM EST GlobeNewswire 3 Best Stocks to Buy Now, 4/3/2024, According to Top Analysts databasesystemscorpcallapplicationsWebApr 10, 2024 · Zacks Equity Research. April 10, 2024, 9:23 AM · 3 min read. It has been a rough year so far for late-stage biopharmaceutical company, Cytokinetics, Incorporated … bitlife mod apk bitzen and god mode